Prescription Opioid Addiction Care

Key takeaway

Prescription opioid use disorder is treated with methadone, buprenorphine, or naltrexone. CDC says detox alone raises the risk of return to use and overdose death, and that clinicians should not stop long-term pain opioids abruptly except for life-threatening warning signs. A household chart is not a taper.

Last updated: Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

The pills started as a prescription for pain, and now stopping feels as dangerous as continuing. A taper you design from a blog is the wrong tool. CDC's 2022 Clinical Practice Guideline for Prescribing Opioids for Pain says clinicians should offer or arrange evidence-based medication for patients with opioid use disorder. It says detoxification on its own, without those medications, is not recommended, because the risks of resuming drug use, overdose, and overdose death go up. NIDA names the FDA-approved medicines that help people stop or reduce opioid use: methadone, buprenorphine, and naltrexone. A clinician-guided change in pain medicine and treatment of the use disorder are different jobs. No home taper is printed here.

If breathing is slow, the person will not wake, or speech is suddenly slurred with heavy sedation, call 911. Use naloxone if you have it. For a mental health crisis, call or text 988.

Pain treatment and addiction treatment are different jobs

CDC's Recommendation 5 is about people already receiving opioid therapy for pain. Clinicians should weigh benefits and risks before they change the dose. If benefits outweigh risks, they should optimize nonopioid care while continuing the opioid. If benefits do not outweigh risks, they should optimize other therapies and work with the patient to taper gradually to a lower dose or, when the individual situation warrants it, to taper and stop. Unless there are signs of a life-threatening problem, such as impending overdose (CDC's examples include confusion, sedation, or slurred speech), opioid therapy should not be stopped abruptly, and clinicians should not rapidly reduce higher doses.

That is an instruction to clinicians. It is not a calendar a household can follow. The guideline does not invite patients to cut a percentage of a pill each week from a chart on the internet. Vomiting, sweating, tremor, and rebound pain are reasons to call the prescriber, not reasons to invent the next cut. A percentage without an exam is how people get hurt.

Recommendation 12 is the addiction recommendation. If opioid use disorder is present, offer or arrange medication treatment. Talk about the concern without judgment. Assess rather than accuse. Stigma keeps people away. CDC calls opioid use disorder a chronic, treatable illness from which people can recover. Detox alone is the path the guideline rejects.

The 2022 guideline also describes a specific mistake that followed the 2016 pain guideline. Some policies applied the pain recommendations to medications for opioid use disorder, the treatment once called medication-assisted treatment. CDC says that misapplication, along with rapid tapers and abandoning patients, was not consistent with the 2016 guideline and contributed to harm, including withdrawal, worsening pain, distress, overdose, and suicidal ideation. A schedule meant for oxycodone prescribed for pain is not a schedule for methadone or buprenorphine prescribed for opioid use disorder. Do not copy one onto the other. Stopping a medicine for opioid use disorder because a residential program prefers a drug-free building can be the same kind of error. Ask whether the medicine continues. What each medicine does, where methadone is dispensed, and why naltrexone usually waits until other opioids have cleared, without doses, is on the medication guide.

What the three medicines are for

NIDA says methadone, buprenorphine, and naltrexone help people stop or reduce opioid use, and that they reduce the risk of overdose death. Lofexidine is approved to ease withdrawal symptoms. It is not a substitute for the three as treatment of the disorder. Fewer than 1 in 5 people with opioid use disorder receive the medications, which is a gap in care, not a reason to skip them.

Methadone for opioid use disorder comes through a certified opioid treatment program, not as a bottle you start on your own from an old pain prescription. Buprenorphine can be prescribed in ordinary clinical settings by a clinician with the authority to prescribe it. Naltrexone blocks opioid receptors and is not an opioid. Starting it too soon can precipitate withdrawal. The timing is the prescriber's decision. Do not take a first dose alone to see what happens.

NIDA says that when methadone or buprenorphine is taken as prescribed for this disorder, it does not produce the same intense high as illegal opioids. That is the answer to "you are just replacing one drug with another." It is not permission to share a prescription. Using someone else's buprenorphine, or adding alcohol or a benzodiazepine, can still be dangerous. Why those sedatives cannot be stopped overnight is on the benzodiazepine guide. Tell every prescriber about both.

SAMHSA's overdose toolkit says opioid withdrawal is usually not fatal, though severe dehydration during withdrawal can be dangerous. The larger danger CDC names is what happens if the opioid use disorder is treated with detox alone: a return to use, then overdose, then death, because tolerance fell while the craving did not. How that differs from alcohol and benzodiazepine withdrawal is on the detox guide. If the pills did not come from a pharmacy, the companion is the fentanyl guide. Counterfeit tablets can contain fentanyl. You cannot see it.

Naloxone belongs in the house

CDC's reversing-overdose page says naloxone can reverse an overdose from heroin, fentanyl, and prescription opioid medications when it is given in time. It tells people who take prescribed higher-dose opioids, people who use opioids and benzodiazepines together, and people who use illegal opioids to carry naloxone and to tell someone else where it is. You cannot use it on yourself. Naloxone is available over the counter. It does not treat the use disorder, and it wears off. The practical steps are on the overdose guide. Why the emergency call still matters after naloxone is on the Good Samaritan overview.

Pregnancy is its own rule. CDC says not to stop opioids quickly during pregnancy. NIDA says methadone and buprenorphine are recommended for pregnant patients with opioid use disorder. Those sources are quoted at length on the pregnancy guide. A positive test is a reason to call the prescriber, not a reason to flush the bottle.

What to ask the prescriber and the program

Are we changing a pain prescription, treating opioid use disorder, or both?
If the pain dose needs to come down, who is managing that taper, and what warning signs pause it?
If this is opioid use disorder, which of methadone, buprenorphine, or naltrexone is being offered, and why not detox alone?
Will a residential program continue the medicine, or does admission require stopping it?
Who else in the household knows where the naloxone is?

FindTreatment.gov lists opioid treatment programs and other facilities. Call or text (800) 653-9376 if you need help finding a program that continues medication.

Do not wait for a callback to decide whether to cut today's dose. Ask the prescriber.

Additional Resources

Sources cited on this page:

Common Questions

Can I taper my pain pills at home using a chart I found online?

No. CDC's 2022 guideline tells clinicians not to discontinue opioid therapy abruptly, and not to rapidly cut higher doses, unless there are signs of a life-threatening problem such as impending overdose. The pace is individualized and done with the patient. No percent-per-week schedule is printed here. Call the prescriber. Call 911 for slowed breathing.

Is physical dependence the same as opioid use disorder?

Not always. People can become physiologically dependent on a prescribed opioid and still need a clinician if the dose changes. Opioid use disorder is the diagnosable illness. CDC says that if that disorder is present, clinicians should offer or arrange medication treatment. A clinician sorts which label fits. Do not stop the medicine to test it.

What medicines treat prescription opioid addiction?

NIDA says the FDA-approved medicines that help people stop or reduce opioid use are methadone, buprenorphine, and naltrexone. Lofexidine eases withdrawal symptoms and is not itself treatment of the disorder. Methadone for this disorder comes from opioid treatment programs. Do not start, share, or stop these medicines on your own.

Why not just detox and be done?

CDC's 2022 guideline says detoxification by itself, without medications for opioid use disorder, is not recommended, because the risks of resuming drug use, overdose, and overdose death go up. SAMHSA notes that opioid withdrawal is usually not fatal. The fatal risk is often the next use, when tolerance is lower. The medication guide explains the three medicines without doses.

Should I stop buprenorphine the way I would taper oxycodone?

No. CDC's 2022 guideline says applying pain-opioid rules to medications for opioid use disorder was a misreading of the earlier pain guideline and contributed to harm. A pain taper and a change in methadone or buprenorphine are different clinical decisions. Ask the prescriber who manages that medicine. Do not copy a pain-clinic schedule onto it.